Cortical and trabecular bone at the radius and tibia in male and female adolescents with Down syndrome:a peripheral quantitative computed tomography (pQCT) study by Gonzalez de Aguero, Alejandro et al.
Aberystwyth University
Cortical and trabecular bone at the radius and tibia in male and female
adolescents with Down syndrome
Gonzalez de Aguero, Alejandro; Vicente-Rodríguez, G; Gómez-Cabello, A; Casajús, J A
Published in:
Osteoporosis International
DOI:
10.1007/s00198-012-2041-7
Publication date:
2013
Citation for published version (APA):
Gonzalez de Aguero, A., Vicente-Rodríguez, G., Gómez-Cabello, A., & Casajús, J. A. (2013). Cortical and
trabecular bone at the radius and tibia in male and female adolescents with Down syndrome: a peripheral
quantitative computed tomography (pQCT) study. Osteoporosis International, 24(3), 1035-1044.
https://doi.org/10.1007/s00198-012-2041-7
General rights
Copyright and moral rights for the publications made accessible in the Aberystwyth Research Portal (the Institutional Repository) are
retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the
legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the Aberystwyth Research Portal for the purpose of private study or
research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the Aberystwyth Research Portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
tel: +44 1970 62 2400
email: is@aber.ac.uk
Download date: 03. Oct. 2019
ORIGINAL ARTICLE
Cortical and trabecular bone at the radius and tibia in male
and female adolescents with Down syndrome: a peripheral
quantitative computed tomography (pQCT) study
A. González-Agüero & G. Vicente-Rodríguez &
A. Gómez-Cabello & J. A. Casajús
Received: 7 March 2012 /Accepted: 23 April 2012 /Published online: 9 June 2012
# International Osteoporosis Foundation and National Osteoporosis Foundation 2012
Abstract
Summary We aimed to describe the structure and strength of
the tibia and radius of adolescents with Down syndrome. We
observed that despite higher levels of volumetric bone
mineral density in determined skeletal sites, they are at
higher risk of developing osteoporotic fractures in the
future due to their lower bone strength indexes.
Introduction The aims of the study were to describe the
cortical and trabecular volumetric bone mineral density
(vBMD), bone mineral content (BMC), area, and bone
strength in adolescents with Down syndrome (DS) and to
compare them with adolescents without disabilities.
Methods Thirty adolescents (11 girls) with DS and 28without
disabilities (10 girls) participated in the study. Peripheral
quantitative computed tomography measurements were taken
at proximal and distal sites of the tibia and radius. Values of
total, trabecular, and cortical BMC; vBMD; and area were
obtained of each scan. Cortical thickness and endosteal and
periosteal circumferences were also measured, and different
bone strength indexes were calculated. Student’s t tests were
applied between groups.
Results The DS group showed greater vBMD at distal radius,
BMC at proximal radius, and total and cortical vBMD at
proximal tibia. The non-DS group showed higher total and
trabecular area at the distal radius and total, cortical, and
trabecular BMC and area at distal tibia. Higher values of
periosteal and endosteal circumference and bone strength
were also found in non-DS group.
Conclusions From these results, it can be believed that even
with higher vBMD in determined skeletal sites, adolescents
with DS are at higher risk of suffering bone fractures due to
an increased fragility by lower resistance to load bending or
torsion.
Keywords Body composition . Bone geometry .
Bone strength . Osteoporosis . vBMD
Introduction
Osteoporosis-related fractures constitute a major public
health concern in the nowadays society [1, 2]. The fracture
risk depends on several factors such as bone mineral density
(BMD), bone geometry, or bone strength [3, 4]. Several
studies showed an increased prevalence of osteopenia and
osteoporosis in persons with intellectual disability, identifying
Down syndrome (DS) as one of the main contributors for low
BMD in those persons [5–7]. The increment in the lifespan of
persons with DS occurred over the last decades allows to
believe that osteoporotic diseases are likely to appear in a
relatively close future in this population [8, 9].
Numerous studies performed with dual energy X-ray
absorptiometry (DXA) showed lower levels of bone mass
in persons with DS compared with their counterparts without
DS at all ages [10–17]. Despite of this, the body composition
of adolescents with DS has not been studied in detail, and
several issues are still pending to be considered [18]. DXA use
a two-dimensional image of the bone (often expressed as
“areal” BMD; in grams per square centimeter) which does
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not provide information about volumetric BMD (vBMD) and
does not differentiate cortical and trabecular bone. As small
stature and stunted growth are among the most common
clinical characteristic of persons with DS [19, 20] and it is
known that DXA tends to underestimate BMD in those who
are smaller than normal size for chronological age (even
when adjusting values for height) [21], it is possible to
hypothesize that DXA is not the best method for measuring
BMD in persons with DS. Even with this, a couple of studies
calculated an estimation of vBMD from data obtained with
DXA, based on simple geometric cylindrical models. These
studies found differences in vBMD at lumbar spine in adults
with DS, but not in adolescents at lumbar spine or femoral
neck compared with those without DS [12, 15]. However,
these assumptions have not been yet confirmed using other
techniques of bone assessment which actually measure
vBMD.
As it has been observed, osteoporosis is highly related
with BMD; however, strength indexes and, therefore, fracture
risk have a high relationship with structural aspects of the
bone such as cortical thickness and bone cross-sectional area,
among others. Peripheral quantitative computed tomography
(pQCT) is an alternative bone densitometry technique that
allows evaluating separately the cortical and trabecular bone.
This technique is also able to assess actual vBMD at
peripheral sites as well as estimate geometric properties
of bone which are related to bone strength, going be-
yond the scope of current DXA determinations. The low
dose of radiation produced by pQCT (slightly lower
than by DXA) makes this method suitable for using
with pediatric populations.
Though many studies have detected lower areal BMD in
persons with DS, few have examined other measurements of
bone strength such as actual vBMD, and no one of them has
actually measured those values, only estimations were used.
Therefore, the main aims of this study were to assess the
cortical and trabecular vBMD, bone mineral content
(BMC), area, and bone strength at proximal and distal sites
of tibia and radius in adolescents with DS and to
compare these results with healthy counterparts without
disabilities.
Methods
Participants
A total sample of 30 adolescents (11 females, 19 males) with
DS living at home, between 11.5 and 20 years old, were
recruited from different special schools and institutions
within the region of Aragon, in Spain. Another individually
age-matched sample of 28 adolescents (10 females, 18
males) without DS was also recruited from regular schools
in this region (non-DS group). All the adolescents without
DS were healthy, without known illness, and had been
medication-free for at least 6 months before the tests. Both
parents and children were informed about the aims and
procedures of the study, as well as the possible risks and
benefits, and then, a letter of written informed consent was
obtained from all the included participants and/or their parents
or guardians. The study was performed in accordance with the
Helsinki Declaration of 1961 (revised in Edinburgh, 2000)
and was approved by the Research Ethics Committee of the
Government of Aragon (CEICA, Spain).
Anthropometric
All participants were measured with a stadiometer without
shoes and the minimum clothes to the nearest 0.1 cm (SECA
225, SECA, Hamburg, Germany) and weighted to the nearest
0.1 kg (SECA 861, SECA, Hamburg, Germany). Body mass
index (BMI) was calculated as weight (in kilograms) divided
by height (in square meters).
Pubertal status assessment
Pubertal development was determined by direct observation
according with the five stages proposed by Tanner and
Whitehouse [22].
Bone assessments by peripheral quantitative computed
tomography
pQCT measurements were taken at two sites of the radius and
three sites of the tibia using a Stratec XCT-2000 L pQCT
scanner (Stratec Medizintechnik, Pforzheim, Germany). The
device is a translate-rotate, small bore computed tomography
scanner that acquires a trans-axial image. The X-ray source is
a narrow fan beam with an effective width of 2.3 mm and a
total radiation dose associated lower than 2 μSv. Images were
acquired with an in-plane voxel dimension of 0.2 mm
(0.008 mm3). To ensure machine stability, the pQCT device
was assessed daily based on a quality control phantom (Stratec
Medizintechnik, Pforzheim, Germany), which includes soft
tissue equivalent material. The coefficient of variation
between measurements is lower than 1 % for that phantom.
Scanning procedure
For each participant, the non-dominant upper and lower
limbs were selected for measurements. Participants were
seated in a stationary chair, adjusted to the appropriate
height. For the radius scans, the length of the bone from
humeroradial joint cleft to the styloid process was measured.
For the tibia scans, the length of the bone from the distal end
of the medial malleolus to the medial knee joint cleft was
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measured. A radial or tibial adjustable fasten was used to
hold the limb and to limit motion during the scans. Every
limb was centered in the imagining field. The scanner was
positioned on the distal radius or distal tibia, and a coronal
computed radiograph (scout view) was performed to manually
locate a reference line on the distal end of either the radius or
the tibia. The measurement sites were located proximal to this
reference line by a distance corresponding to 4 % (distal
radius) and 66 % (diaphyseal radius) of the forearm
length, and 4 % (distal tibia) and 38 % (diaphyseal
tibia) of the tibia length, as previously described [23].
For muscle, subcutaneous fat, and bone cross-sectional
area, the measurement site was at 66 % of the length of
the tibia, where the largest calf diameter is typically
located. See Fig. 1a–c for the different scan sites. Each
scan required approximately 90 s, with some variability
depending upon the cross-sectional size of the upper or
lower limb.
Measurement parameters
Version 6.20 of the manufacturer’s software was used to
analyze and select thresholds. Several parameters were
determined at the described bone sites: (1) BMC (in
grams per 1 cm slide): total BMC (TOT_BMC), trabecular
BMC (TRAB_BMC), and cortical BMC (CRT_BMC); (2)
cross-sectional area of bone (in square millimeters): total
cross-sectional area (TOT_A), trabecular area (TRAB_A),
and cortical area (CRT_A); and (3) vBMD (in milligrams
per cubic centimeter): total vBMD (TOT_vBMD), trabecular
vBMD (TRAB_vBMD), and cortical vBMD (CRT_vBMD).
Also cortical thickness (CRT_THK, in millimeters), endosteal
circumference (ENDO_CIR, in millimeters), and periosteal
circumference (PERI_CIR, in millimeters) were measured at
66 % of the tibia. A threshold of 280 mg/cm3 was used to
detect periosteal surface of the bone and to distinguish
trabecular from cortical bone. TRAB_vBMD and
TRAB_BMC were determined from a central area covering
Fig. 1 Different scan sites for the lower limb assessment
Table 1 Descriptive characteristics of the sample
Group Boys Girls
Group n Mean±SD n Mean±SD n Mean±SD
Age (years) DS 30 15.52±2.59 19 16.27±2.39 11 14.25±2.50
Non-DS 28 14.94±2.23 18 15.17±2.00 10 14.52±2.67
Weight (kg) DS 30 52.39±10.94 19 53.94±8.33 11 49.76±14.50
Non-DS 28 56.20±12.57 18 58.01±13.67 10 53.32±10.60
Height (cm) DS 30 150.91*±9.43 19 153.75*±8.85 11 146.09*±8.76
Non-DS 28 162.00±12.35 18 165.10±11.61 10 157.04±12.43
Tanner stage (I, II, III, IV, V) DS 30 1/2/6/6/15 19 0/0/3/6/10 11 1/2/3/0/5
Non-DS 28 1/3/7/0/17 18 1/2/4/0/11 10 0/1/3/0/6
BMI (kg/m2) DS 30 22.95±4.34 19 22.79±2.69 11 23.24±6.44
Non-DS 28 21.14±2.61 18 20.94±2.87 10 21.45±2.23
Tibia length (mm) DS 30 323.85*±27.21 19 330.63*±26.26 11 313.00*±26.37
Non-DS 28 361.79±31.48 18 372.78±31.31 10 342.00±21.11
Radius length (mm) DS 30 223.33*±19.06 19 231.76*±18.20 11 209.00*±9.94
Non-DS 28 247.32±22.26 18 255.83±22.64 10 232.00±10.59
DS group with Down syndrome, Non-DS group without Down syndrome, BMI body mass index, SD standard deviation
*p<0.05 between DS and non-DS
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45 % of the total bone cross-sectional area. In the cortical
compartment, many voxels are only partially occupied by
cortical bone; however, at a threshold of 710 mg/cm3, the
number of such voxels that are included in the analysis is
equivalent to the number excluded. Bone strength was
established with respect to torsion (polar stress strain
index or SSI, in cubic millimeters), and bending (fracture load,
in Newton) both with respect to the X- or Y-axis; also the bone
strength index (BSI, in square milligrams per quartic
millimeter) was calculated as previously described
[24–26]:
BSI ¼ TOT vBMD2  TOT A
SSI ¼ P dx2  Av  Dv=PCoD
 
=dxmax
where d is the distance from a cortical voxel to the
x-axis, Av is the area of the voxel, Dv is the density of
the voxel, and PCoD is the estimated physiological
“maximal” cortical bone density (1,200 mg/cm3).
Fig. 2 Bone variables at the 4 % of the length of the tibia. DS Down
syndrome; *p<0.05 between DS and non-DS
Fig. 3 Bone variables at the 4 % of the length of the radius. DS Down
syndrome; *p<0.05 between DS and non-DS
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For the analysis of muscle cross-sectional area, the region
of interest was defined to include the entire matrix (skin,
subcutaneous tissue, muscle, and bone). A threshold set at
40 mg/cm3 was used within this region, to determine the
total area of the muscle, and the total bone was assessed
with a threshold of 710 mg/cm3. The total area of skin and
subcutaneous fat was identified using a threshold of 100 mg/
cm3. Subsequently, the total bone area and total areas of skin
and subcutaneous fat were deducted from the region of
interest to yield the total muscle area which was found
between the thresholds of 40 and 710 mg/cm3.
Statistics
The Statistical Package for the Social Sciences (version 15.0
for Windows) was used to conduct statistical analyses.
Descriptive statistics including number of participants
(n), mean, and standard deviation values were calculated
for each variable. The normality in the distribution of
the variables was established by using Kolmogorov–
Smirnov tests. To compare DS and non-DS groups,
two-sided Student’s t tests were performed. For avoiding
possible influences of height in bone parameters, all the
analyses were repeated using bone length as a covariate
(analysis of covariance). Every analysis was executed
with all the participants within a group as a whole
and separately by gender. Effect size statistics using
Cohen’s d (G*Power Version 3.1.2) were calculated
[27]. Taking into account the cutoff established by
Cohen, the effect size can be small (under 0.2), medium
(over 0.2 and under 0.5), or large (over 0.8). Statistical
significance was set at p<0.05.
Results
Participant characteristics
Table 1 shows descriptive characteristics of participants by
condition and gender. There were no differences between
groups for age, weight, Tanner stage distribution, or BMI,
but DS boys and girls resulted significantly smaller than
boys and girls without DS, respectively (both p<0.05). Also
DS adolescents showed shorter tibia and radius than those
without DS (all p<0.05).
Distal radius and tibia
Scans with a high level of motion artifact (the software
assesses each analysis as good, invalid, or aborted) were
excluded, and sample size could not be the same for each
variable. As explained in the operator’s manual provided by
the manufacturer, the factors which determine the artifacts
are positioning of patient, selection of the scan positions,
movements of the subject, and/or interference with other
devices.
Figure 2a–c displays the pQCT variables measured at the
4 % distal tibia. The DS adolescents as a group and also
separated by gender showed lower mean values of
TOT_BMC, TOT_A, TRB_BMC, and TRB_A than their
counterparts without DS (all p<0.05; Cohen’s d ranged from
Fig. 4 Bone variables at the 38 % of the length of the tibia. DS Down
syndrome; *p<0.05 between DS and non-DS
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1.8 to 3.3). Figure 3a–c summarizes the pQCT variables
measured at 4 % distal radius in DS and non-DS adolescents.
The DS adolescents as a group and the DS boys separately
showed higher values of TOT_vBMD than the non-DS group
and non-DS boys (both p<0.05; Cohen’s d 0.7 and 0.73,
respectively). The DS adolescents as a group and the DS girls
separately demonstrated lower TOT_A and TRB_A than their
respective non-DS counterparts (both p<0.05; Cohen’s d 0.76
for group TOT_A and over 0.8 for the rest of variables).
Diaphyseal radius and tibia
In Fig. 4a–c is displayed the bone variables and in Table 2
geometric variables and strength indexes at the 38% diaphyseal
site of the tibia. The DS group as a whole and also separately by
gender showed significantly lower values for TOT_BMC,
TOT_A, CRT_BMC, CRT_A, PERI_CIR, ENDO_CIR, SSI
(in both X- and Y-axis, and polar), and fracture load (in both
X- and Y-axis) (all p<0.05; Cohen’s d ranged from 0.86 to
1.42). The DS group and also the boys with DS separately
demonstrated higher TOT_vBMD than the non-DS group and
boys, respectively; the boys with DS also showed higher
CRT_vBMD than the non-DS boys (all p<0.05; Cohen’s d
0.75, 0.79, and 1.04, respectively). Figure 5a–c shows data of
bone and Table 3 geometry and strength at the 66 % of the
radius. At this site, the DS adolescents as a whole and also boys
with DS showed significantly higher values for TOT_BMC
than their respective non-DS counterparts (both p<0.05;
Cohen’s d 0.57 and 0.69, respectively).
Bone, subcutaneous fat, and bone cross-sectional area
Table 4 summarizes the results for muscle, fat, and bone
area at the 66 % site of the tibia. The DS group and the girls
with DS showed lower levels of muscle area than the non-
DS group and girls, respectively; also lower levels of bone
cross-sectional area were observed in the DS group as a
whole and separately by genders (all p<0.05; Cohen’s d for
the whole group muscle area 0.61 and over 0.8 for the rest of
variables). Further adjustment by bone length did not
substantially change the results (data not shown).
Discussion
In this cross-sectional study, we investigated the differences
between trabecular microstructure and cortical bone size,
among other parameters, between adolescents with and
Table 2 Geometric variables and strength indexes at the 38 % of the length of the tibia
Group Boys Girls
Group n Mean±SD n Mean±SD n Mean±SD
CRT_THK (mm) DS 26 4.53±0.53 16 4.75±0.47 10 4.18±0.43
Non-DS 28 4.83±0.73 18 5.02±0.64 10 4.49±0.79
PERI_CIR (mm) DS 26 61.40*±4.99 16 63.56*±4.39 10 57.96*±3.96
Non-DS 28 69.05±6.91 18 71.44±6.59 10 64.74±5.39
ENDO_CIR (mm) DS 26 32.93*±3.65 16 33.70*±3.87 10 31.70*±3.04
Non-DS 28 38.68±5.04 18 39.88±4.23 10 36.52±5.87
FRC_LOAD_X (N) DS 26 2,253.16*±610.21 16 2,543.14*±539.29 10 1,789.19*±401.15
Non-DS 28 3,215.14±966.90 18 3,509.75±914.86 10 2,684.86±858.90
FRC_LOAD_Y (N) DS 26 1,886.78*±395.65 16 2,052.78*±327.45 10 1,621.17*±358.82
Non-DS 28 2,734.93±841.45 18 3,045.99±808.21 10 2,175.01±590.27
SSIX (mm3) DS 26 532.30*±133.72 16 706.43*±149.80 10 497.00*±111.43
Non-DS 28 787.99±269.79 18 974.93±254.13 10 745.79±238.58
SSIY (mm3) DS 26 524.11*±109.9 16 570.22*±90.96 10 450.32*±99.67
Non-DS 28 759.7±233.73 18 846.11±224.50 10 604.17±163.96
SSI_POL (mm3) DS 26 625.88*±169.5 16 706.43*±149.80 10 497.00*±111.43
Non-DS 28 893.09±268.58 18 974.93±254.13 10 745.79±238.58
BSI (mg2/mm4) DS 26 2,325.16±457.43 16 2,517.7±396.41 10 2,017.09±384.67
Non-DS 28 2,641.08±707 18 2,776.74±695.1 10 2,396.88±695.6
DS group with Down syndrome, Non-DS group without Down syndrome, SD standard deviation, CRT_THK cortical thickness, ENDO endosteal
circumference, PERI periosteal circumference, FRC_LOAD fracture load (axes X and Y), SSI strength strain index (axes X and Y, and polar), BSI
bone strength index
*p<0.05 between DS and non-DS
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without DS, using pQCT. To the best of our knowledge, this
is the first study examining these variables on this
determined population. The main finding of this study
is that despite higher vBMD was found in some regions
of the tibia and radius in adolescents with DS, their
lower levels of BMC and area in total, cortical, and
trabecular bone and their bone geometry lead them to
an increased fracture risk.
Differences between adolescents with and without DS
The assurance of previous studies demonstrating low levels
of areal BMD at whole body and critical regions measured
with DXA in persons with DS [11, 12, 14–16] made us to
suppose that lower values measured with pQCT could also
be found in this population. Conversely to that, our results
indicated higher values of total vBMD and BMC at the
radius and total and cortical vBMD at the tibia in adolescents
with DS compared with those without. Taking into account
the previous results, it could be assumed that adolescents with
DS are not at higher risk of bone fractures than their non-DS
peers. However, several factors account for bone strength and
therefore for the risk of suffering a fracture; those factors
include BMC, area, and geometry among others. In fact,
Kontulainen et al. found that greater than 80 % of the variance
in failure moment at diaphyseal site was predicted by total and
cortical are and content, geometry, and SSI [26]. In this study,
lower levels of total, trabecular, and cortical content and area
and smaller periosteal and endosteal circumferences were
observed in adolescents with DS compared with those
without, leading them to a diminished fracture load and
SSI.
Despite no studies to the date were carried out pQCT
measurements in a population with DS, some of the previous
studies calculated an estimate of vBMD from the data
obtained with DXA based on geometric cylindrical models
[12, 15]. Baptista et al. [15] found lower vBMD at lumbar
spine in adults (over 20 years), but not in adolescents with DS
compared with their counterparts without DS, and González-
Agüero et al. [12] confirmed those results in another sample of
adolescents with DS and also found no differences at the
femoral neck. Both studies were performed with DXA and
examined different body regions than ours; nevertheless,
authors believe that our results reinforce their postulation that
adolescents with DS have not a deficit in vBMD compared
with their counterparts without DS and that differences start to
appear later in life.
For possible sex differentiations in bone development,
we explored differences between DS and non-DS groups
separately by gender. In general, the results observed with
all participants within a group as a whole did not differ from
those observed separately, with the exception that girls with
DS did not show higher values than non-DS girls in any
variable and that boys with DS did not show lower total and
trabecular area at the radius neither cross-sectional muscle area
than non-DS boys. The reason for these gender differences
could be that young females with DS are poorer at acquiring
bone mass than young males with DS, as it was hypothesized
in a previous study [12].
Some limitations to this study should be recognized.
Despite the number of participants was comparable to other
studies performed with pQCT in populations with special
Fig. 5 Bone variables and strength indexes at the 66 % of the length of
the radius. DS Down syndrome; *p<0.05 between DS and non-D
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characteristics [23, 28–31], the specificity of the condition
and the limited age range became complicated to increase
the sample size. Regarding this number of participants, the
large effect sizes observed in the vast majority of the
differences indicate a substantial biological magnitude of
the results. In addition, this study has been carried out
with healthy non-overweight Caucasian adolescents with
Down syndrome; therefore, the results only apply to this
population. Further studies are needed in order to confirm
these findings in other populations with Down syndrome such
as overweight/obese or adult persons. As strengths, our study
was the first in assessing actual vBMD, as well as other
important structural architectural bone properties and indexes
in a population of persons with DS, including both genders,
and was performed in a crucial age for acquiring bonemass. A
longitudinal study could help to corroborate the hypothesis
that the low vBMD in adult populations with DS is due to a
lower acquisition during the most important years of
accumulation.
Some research has been made aiming to improve the body
composition of adolescents with DS, finding reductions in the
percentage of fat mass and increments in the lean and bone
Table 3 Geometric variables
and strength indexes at the 66 %
of the length of the radius
DS group with Down syndrome,
Non-DS group without Down
syndrome, SD standard deviation,
CRT_THK cortical thickness,
ENDO endosteal circumference,
PERI_CIR periosteal circumfer-
ence, FRC_LOAD fracture load
(axes X and Y), SSI strength strain
index (axes X and Y, and polar),
BSI bone strength index
Group Boys Girls
Group n Mean±SD n Mean±SD n Mean±SD
CRT_THK (mm) DS 26 2.00±0.50 16 2.04±0.49 10 1.94±0.52
Non-DS 28 1.96±0.41 18 2.00±0.45 10 1.89±0.34
PERI_CIR (mm) DS 27 42.76±6.97 17 45.45±7.54 10 38.19±1.63
Non-DS 28 39.92±4.39 18 41.52±4.44 10 37.05±2.54
ENDO_CIR (mm) DS 27 30.54±8.52 17 33.21±9.45 10 25.99±3.79
Non-DS 28 27.60±4.22 18 28.94±4.08 10 25.18±3.44
FRC_LDX (N) DS 27 491.04±225.28 17 578.59±234.67 10 342.21±98.11
Non-DS 28 469.39±167.33 18 518.89±183.31 10 380.27±82.47
FRC_LDY (N) DS 27 564.45±217.04 17 651.98±220.34 10 415.66±103.47
Non-DS 28 520.29±201.47 18 583.13±214.78 10 407.18±111.91
SSIX (mm3) DS 26 136.40±62.58 17 160.72±65.19 10 95.06±27.25
Non-DS 28 130.39±46.48 18 144.14±50.92 10 105.63±22.91
SSIY (mm3) DS 26 156.79±60.29 17 181.11±61.20 10 115.46±28.74
Non-DS 28 144.53±55.96 18 161.98±59.66 10 113.11±31.09
SSI_POL (mm3) DS 26 241.03±102.08 17 276.05±108.48 10 181.51±54.11
Non-DS 28 242.94±88.92 18 270.60±93.80 10 193.16±53.06
BSI (mg2/mm4) DS 26 714.00±232.29 17 757.09±254.53 10 640.75±176.74
Non-DS 28 605.40±195.57 18 626.55±221.21 10 567.32±140.74
Table 4 Cross-sectional muscle, subcutaneous fat, and bone are at 66 % of the length of the tibia
Group Boys Girls
Group n Mean±SD n Mean±SD n Mean±SD
Area (mm2)
Total muscle DS 24 5,544.55*±1,208.93 15 6,089.10±972.51 9 4,636.97*±1,031.54
Non-DS 28 6,342.96±1,362.37 18 6,735.17±1,396.20 10 5,637.00±1,012.23
Total fat DS 26 2,914.80±1,940.51 16 2,818.22±2,117.13 10 3,069.33±1,716.52
Non-DS 28 2,510.56±901.00 18 2,203.51±856.13 10 3,063.25±723.16
Total bone DS 26 301.95*±48.49 16 322.89*±44.44 10 268.45*±34.84
Non-DS 28 383.05±76.46 18 409.43±74.34 10 335.58±56.58
DS group with Down syndrome, Non-DS group without Down syndrome, SD standard deviation
*p<0.05 between DS and non-DS
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masses over a relatively short period of time [32–34].
Therefore, interventional studies using specifically designed
training programs could help adolescents with DS to enhance
some parameters of trabecular and/or cortical BMC and area,
and bone strength.
In conclusion, the current study provides evidence that
adolescents with DS have a tendency toward lower cortical
and trabecular BMC and area, but not vBMD at several sites
of tibia and radius compared with age-matched adolescents
without DS. This establishes that our population study is at
higher risk of bone fractures due to decreased bone strength
regarding bending and torsion. Longitudinal studies aiming
to identify critical periods of bone development may help to
corroborate the hypothesis that lower vBMD appears in
persons with DS after the age of 20.
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